We use cookies to better understand how you use our site and to improve your experience by personalizing content. Please review our updated Privacy Policy and Terms of Use. If you accept the use of cookies, please click the "I accept" button.I acceptI declineX
Skip navigational links

AHLA News & Analysis


February 10, 2020

Lawmakers Raising Concerns Regarding FDA’s Oversight Of Chinese Drugs Amid Coronavirus Outbreak 

Politico (2/7, Owermohle) reported lawmakers are raising concerns regarding the “U.S. reliance on foreign drug manufacturing amid the...coronavirus outbreak that has pushed FDA inspectors out of China.” The outbreak “could spark medical product shortages if the epidemic is not resolved swiftly, experts say.” The agency “told POLITICO that manufacturers of FDA-regulated products have not reported any impacts on the supply chain that are creating the potential for shortages of critical medical products – but the situation is evolving.”

© 2018 American Health Lawyers Association. All rights reserved. 1620 Eye Street NW, 6th Floor, Washington, DC 20006-4010 P. 202-833-1100 F. 202-833-1105